Jazz Pharmaceuticals Public Limited Company
(NASDAQ: JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

229.550 -

+0.780 (+0.34%)
Jarak 227.640 - 231.430   (1.66%)
Buka 228.960
Tutup Terdahulu 228.770
Harga Beli 193.880
Beli Purata 100
Jual Beli 258.930
Purata Jual 1
Purata 685,869
Nilai 168,946,928
Catatan -
Harga tertunda. Dikemas kini pada 19 May 2026 04:15.
Data dikuasakan oleh
Lihat Semua Acara


Loading Chart...

Please login to view stock data and analysis